📈 Stocks
📊 Neutral
Omada Health CEO Sean Duffy Sells 31,457 Shares Under 10b5-1 Trading Plan
CEO Sean Duffy offloaded 31,457 shares of Omada Health in a scheduled transaction, maintaining a substantial $29 million position as he prepares to transition to Executive Chair in early 2027.
Impact
10/10
💡 Key Takeaways
- CEO Sean Duffy sold 31,457 shares at a weighted average price of $23.37 per share.
- The transaction was conducted under a Rule 10b5-1 plan established in March 2026 to ensure regulatory compliance.
- Duffy remains heavily invested in Omada Health with a post-transaction equity value of approximately $28.63 million.
- The CEO is scheduled to step down from his current role on January 1, 2027, to become Executive Chair.
📋 Executive Summary
Omada Health CEO Sean P. Duffy sold 31,457 shares of company stock on September 1, 2026, in a transaction valued at approximately $735,150. The sale, executed under a pre-established Rule 10b5-1 trading plan, included both open-market sales and shares withheld for tax obligations. Duffy retains a significant equity stake in the digital health firm, holding over 1.2 million shares directly and through trusts.
📊 Sentiment Analysis
Sentiment
📊 Neutral
Impact Score
10/10
Asset Class
📈 Stocks
❓ Frequently Asked Questions
No, the sale was executed under a pre-planned Rule 10b5-1 program, which is designed to allow insiders to sell shares at predetermined times to avoid potential conflicts regarding material non-public information.
📰 Source
📅 Originally published:
⚠️ Disclaimer: This content is for training purposes only and should not be considered financial advice. Always conduct your own research before making investment decisions.